Search…

Johnson & Johnson's Teclistamab Injection Approved in China for Patients with Relapsed Multiple Myeloma After First Relapse

22/10/2026

On October 22, Johnson & Johnson announced that the National Medical Products Administration has approved a new indication for TECVAYLI for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy.

Latest

3 m ago

Century Mortgage: Hong Kong banks' remortgage registrations rose 20.6% month-on-month to 1,225 cases in September, up for four consecutive months.

4 m ago

Hong Kong Stock Market Movers | Computing Power Hardware Stocks Lead Declines; Kinwong Electronic (03228.HK) and Yangtze Optical Fibre and Cable (06869.HK) Both Fall Over 12%

5 m ago

The Swiss National Bank noted in the minutes of its latest meeting released on Thursday that the need to intervene in the foreign exchange market to curb the appreciation of the Swiss franc has somewhat diminished. Earlier this year, after the United States launched strikes on Iran, the Swiss National Bank had said it preferred to curb the franc's appreciation through foreign exchange market intervention.

6 m ago

New Stock News | Weiyi Intelligent Manufacturing (03275.HK) Opens IPO Subscription: How Does a "Physical AI Brain" Scale Industrial Embodied Intelligence "from 1 to N"?

6 m ago

Hong Kong Stock Movement | ASMPT (00522.HK) Falls Over 10% in Late Trading; Reportedly SK Hynix Postpones Equipment Orders and Slightly Adjusts Investment Focus

See all latest